Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)

 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
1.8(c) 1.72(c) 1.73(c) 1.76(c) 1.74(c) Last
161 992 79 325 149 334 205 305 119 098 Volume
+2.86% -4.44% +0.58% +1.73% -1.14% Change
More quotes
Company
BioPorto A/S is an in-vitro diagnostics company.It provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies.The company focuses on the diagnosis of obesity, diabetes, primary immune deficiency, and kidney injury.Its products include The NGAL... 
Sector
Pharmaceuticals
Calendar
03/22Earnings Release
More about the company
Latest news on BIOPORTO A/S
11/24 BIOPORTO A/S : Share Capital and Votes
11/19 BIOPORTO A/S : Completion of rights issue and capital increase
11/18 BIOPORTO A/S : Completion of rights issue and capital increase
11/14 BIOPORTO A/S : Managers’ transactions
11/14 BIOPORTO A/S : completes cash issue, private placement
11/11 BIOPORTO A/S : increases the share capital through a cash issue, private placeme..
11/08 BIOPORTO A/S : EPO approves BioPorto’s NGAL Cutoff patent for issue
11/03 BIOPORTO A/S : Interim report, first nine months of 2016
10/10 BIOPORTO A/S : files Pre-Sub application for The NGAL TestTM to the FDA
08/08 BIOPORTO A/S : Jan Kuhlmann Andersen new COO in BioPorto A/S - resigns from the ..
More news
Sector news : Diagnostic & Testing Substances Manufacturers
01:25aDJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Diagnostic & Testing Substances Manufacturers
Advertisement
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Full-screen chart
Technical analysis trends BIOPORTO A/S
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Managers
NameTitle
Peter Mørch Eriksen CEO & Investor Relations Contact
Thomas Magnussen Chairman
Jan Kuhlmann Andersen Chief Operating Officer
Jakob Brix Christensen Chief Financial Officer
Torben A. Nielsen Vice Chairman
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOPORTO A/S-64.11%0
JOHNSON & JOHNSON8.43%303 013
PFIZER INC.-2.54%190 910
ROCHE HOLDING LTD.-17.98%189 262
NOVARTIS AG-19.07%177 818
MERCK & CO., INC.15.85%167 524
More Results